AstraZeneca's partnership with African govts. expanding affordable healthcare for poor
Author: Alpha Nuhu, Daily News (Tanzania), Published on: 8 February 2016
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases...
In support of the Ethiopian Government’s National Strategic Action Plan for Non-Communicable Diseases, last week AstraZeneca launched the Healthy Heart Africa initiative to address the burden of hypertension for low and middle income patients across the Horn of Africa country. This partnership was initiated in late-2015, when an agreement was signed between AstraZeneca and the Ethiopian government to provide a formal partnership framework. Healthy Heart Africa’s expansion into Ethiopia comes on the heels of a successful series of Kenyan demonstration projects launched in October 2014.
Since then, AstraZeneca, in collaboration with the Kenyan Ministry of Health and non-governmental partners, has screened over 1 million Kenyans for hypertension and identified over 150,000 Kenyans living with the condition. Building on the momentum of these successes in Kenya, AstraZeneca alongside the Ethiopian Government will tailor Healthy Heart Africa’s comprehensive, three-pillared framework to the local Ethiopian context.
Related companies: AstraZeneca